Home

SAiGENCI

SAiGENCI is an independent cancer-focused medical research institute located in South Australia; focusing on cancer research and clinical trials, which will include new cutting-edge technologies in immunotherapies and genomics.

Leadership appointments

Professor Christopher Sweeney

Professor Christopher Sweeney has been appointed Director of SAiGENCI.

Read more

Professor Melissa Davis

Professor Melissa Davis has been appointed Program Leader, Computational Systems Oncology.  She commenced with SAiGENCI in March 2022 on a part-time basis until joining the Institute full-time in April 2023.

Read more

Professor Jose Polo

Professor Jose Polo has been appointed Epigenetics Program Leader in SAiGENCI to build the epigenetics capacity within the Institute.  Professor Polo will establish the Adelaide Centre for Epigenetics (ACE) in the Faculty of Health and Medical Sciences. 

Read more

Scientific appointments

Dr Adrienne Sullivan

Dr Adrienne Sullivan will hold a Group Leader joint appointment with the Adelaide Centre for Epigenetics (ACE) and SAiGENCI as Head of Development and Epigenetics Laboratory with ACE and SAiGENCI's Cancer Epigenetics program.

Read more

Professor Lisa Butler

Professor Lisa Butler has been appointed Lead SAiGENCI Associate in SAHMRI, and Prostate Cancer Theme Lead in the Hormone Dependent Cancers Program. She will also lead SAiGENCI’s Graduate Program for HDR and Honours students.

Read more

Associate Professor Luciano Martelotto

Associate Professor Luciano Martelotto has been appointed to establish a Single Cell and Spatial Technologies Lab for SAiGENCI.

Read more

News

09

Dec

Placenta research puts spotlight on early weeks of human pregnancy

A University of Adelaide-led research project will deliver important new knowledge in the first weeks of human development to help reduce infertility and pregnancy complications.

more...

Events

31

Mar

NECTA Drug Development Meeting 2023

After much success in 2022, NECTA are excited to announce the return of the NECTA Drug Development Meeting in 2023 – to be held in-person and broadcast live virtually.

30

Jun

Cold Spring Harbor Laboratory - Single Cell Analysis Course

Cold Spring Harbor Laboratory's Single Cell Analysis training course will be held 30 June to 15 July 2023.

more...